A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
Clinical trial NCT05714969 · COMPLETED
Trial details
- NCT number
- NCT05714969
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-21
- Primary completion
- 2026-04-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.